Physician profile
Michael D Getter
NPI 1265415681
$1,975.28
in general payments reported to CMS, 2019-2025
26 companies · $486 in 2025
The $486 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $380 · 2021: $423 · 2022: $348 · 2024: $24.62 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.62 |
| Travel and Lodging | $225.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $485.94 | 2025 | Amistem |
| Orthofix Medical, INC. | $273.00 | 2019-2022 | |
| Stryker Corporation | $184.55 | 2020-2021 | |
| Baxter Healthcare | $153.59 | 2019-2020 | |
| Medtronic, INC. | $139.66 | 2021-2022 | |
| Seaspine Orthopedics Corporation | $92.00 | 2021 | |
| Spineology INC. | $86.40 | 2020-2022 | |
| Depuy Synthes Sales INC. | $71.30 | 2020-2022 | |
| Nevro Corp. | $59.79 | 2019-2021 | |
| Electronic Waveform Lab, INC. | $58.56 | 2019 | |
| Nuvasive, INC. | $47.38 | 2020 | |
| Bioventus LLC | $35.84 | 2022 | |
| Baudax Bio INC. | $31.20 | 2020 | |
| Arteriocyte Medical Systems, INC. | $29.78 | 2022 | |
| Forte Bio-Pharma LLC | $25.86 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $24.62 | 2024 | Modulus, Acp, Sable |
| Peerless Surgical INC. | $22.35 | 2022 | |
| Vericel Corporation | $22.24 | 2022 | |
| Intrinsic Therapeutics | $20.71 | 2022 | |
| Ermi LLC | $19.98 | 2020 | |
| Innocoll Pharmaceuticals Limited | $17.62 | 2021 | |
| Boston Scientific Corporation | $15.52 | 2019 | |
| Zyla Life Sciences, INC. | $14.76 | 2020 | |
| Si-Bone, INC. | $14.68 | 2022 | |
| Horizon Therapeutics Plc | $14.58 | 2019 | |
| Kci USA, INC. | $13.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Getter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.